North America Pulmonary Drug Delivery Market Forecast 2019-2028

North America Pulmonary Drug Delivery Market Forecast 2019-2028

The North America pulmonary drug delivery market is estimated to harbor a CAGR of 4.40%, during the forecast years of 2019 to 2028. The primary factors propelling the market growth include, advanced technology and affordability, the increased geriatric population, and the rising prevalence of lifestyle-related diseases and other respiratory conditions.

The North America pulmonary drug delivery market growth is assessed across the United States and Canada. According to the Statistics of Canada, over 260,000 patients in Canada, within the age bracket of 50 to 64, suffered from chronic obstructive pulmonary disease (COPD) in 2016. Over the next year, this figure increased to more than 314,000 patients. Similarly, according to the Ontario Lung Association, asthma accounts for at least 80% of the total chronic respiratory disorders in the country. Moreover, the Asthma Society of Canada has also declared an overall surge in the number of people, especially children, with asthma.
On the other hand, non-profit organizations, namely, the Canadian Thoracic Society and COPD Canada, are endeavoring to create awareness regarding alternative treatment methods for asthma as well as COPD. Such initiatives encourage patients to discover and explore innovative options, while subsequently providing lucrative opportunities to the region’s pulmonary drug delivery market. Additionally, the mesh nebulization technology is establishing itself as a standard of care in several medical facilities across the country. As a result, benefits such as potential cost-saving and superior performance further drive the region’s market growth.

Key players operating in the market are, 3M Company, GF Health Products Inc, Agilent Technologies Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Drug Delivery Market
3.2. Development Of Drug Delivery System
3.3. Market Definition
3.4. Key Drivers
3.4.1. Growing Prevalence Of Respiratory Disease
3.4.2. Advancements In Technology
3.4.3. Rising Geriatric Population
3.5. Key Restraints
3.5.1. Stringent Regulation And Patent Expiry
3.5.2. Increasing Drug Recalls And Drug Failures
3.5.3. Side Effects And Risk Associated With The Drugs
4. Key Analytics
4.1. Porter’s Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’s Power
4.1.4. Supplier’s Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Impact Of Covid-19 On Pulmonary Drug Delivery Market
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights
5. Market By Application
5.1. Asthma
5.2. Chronic Obstructive Pulmonary Disease
5.3. Allergic Rhinitis
5.4. Cystic Fibrosis
5.5. Other Applications
6. Market By Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. E-commerce
7. Market By End-user
7.1. Hospitals & Clinics
7.2. Homecare
8. Market By Product
8.1. Metered Dose Inhalers
8.2. Dry Powder Inhalers
8.3. Nebulizer
8.3.1. Pneumatic Nebulizer
8.3.2. Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
8.4. Accessories
9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada
10. Company Profiles
10.1. 3m Company
10.2. Actelion Pharmaceuticals Ltd
10.3. Aerogen
10.4. Agilent Technologies Inc
10.5. Astrazeneca Plc
10.6. Boehringer Ingelheim Gmbh
10.7. Clement Clarke International
10.8. Gf Health Products Inc
10.9. Glaxosmithkline Plc
10.10. Koninklijke Philips Nv
10.11. Merck & Co Inc
10.12. Novartis Ag
10.13. Teva Pharmaceutical Industries Limited
10.14. Vectura Group Plc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings